Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Lung Neoplasms"
topic_facet:"Study Type: Interventional"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Study+Type%3A+Interventional%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (5.162)
1
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) : Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC : A Randomized Trial of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC : A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy : A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer : Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab : Phase I Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Administered Concurrently With Pembrolizumab
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial : Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer : A Phase 1 Open-Label Study of HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients : Combined MEK Inhibitor Trametinib and RTK Inhibitor Anlotinib Therapy in Non-G12C KRAS-Mutant Non-Small Cell Lung Cancer Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[517]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Lung Neoplasms
Filter aufheben
Thema: Study Type: Interventional
Medienart
5.162
Aufsätze
5.162
E-Artikel
5.162
E-Ressourcen
Zeitschriftentitel
5.162
ClinicalTrials.gov
Thema
5.162
610
Lung Neoplasms
Study Type: Interventional
3.123
Carcinoma, Non-Small-Cell Lung
1.970
Phase: Phase 2
1.793
Recruitment Status: Completed
1.227
Recruitment Status: Recruiting
778
Phase: Phase 1
660
Small Cell Lung Carcinoma
655
Phase: Phase 3
636
Recruitment Status: Terminated
571
Recruitment Status: Active, not recruiting
441
Medical Condition: Lung Cancer
389
Recruitment Status: Unknown status
384
Carcinoma
314
Recruitment Status: Not yet recruiting
302
Medical Condition: Non-small Cell Lung Cancer
291
Phase: Phase 1, Phase 2
224
Medical Condition: Non-Small Cell Lung Cancer
222
Medical Condition: Non Small Cell Lung Cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.163
2020-
1.901
2010-2019
98
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.162
Englisch
Haven't found what you're looking for?
Wird geladen...